180 related articles for article (PubMed ID: 26300593)
1. Bleomycin-Treated Chimeric Thy1-Deficient Mice with Thy1-Deficient Myofibroblasts and Thy-Positive Lymphocytes Resolve Inflammation without Affecting the Fibrotic Response.
Cohen PY; Breuer R; Zisman P; Wallach-Dayan SB
Mediators Inflamm; 2015; 2015():942179. PubMed ID: 26300593
[TBL] [Abstract][Full Text] [Related]
2. A Profibrotic Phenotype in Naïve and in Fibrotic Lung Myofibroblasts Is Governed by Modulations in Thy-1 Expression and Activation.
Cohen PY; Breuer R; Wallach-Dayan SB
Mediators Inflamm; 2018; 2018():4638437. PubMed ID: 30002599
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cell apoptosis by fas ligand-positive myofibroblasts in lung fibrosis.
Golan-Gerstl R; Wallach-Dayan SB; Amir G; Breuer R
Am J Respir Cell Mol Biol; 2007 Mar; 36(3):270-5. PubMed ID: 16990614
[TBL] [Abstract][Full Text] [Related]
4. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis.
Hagood JS; Prabhakaran P; Kumbla P; Salazar L; MacEwen MW; Barker TH; Ortiz LA; Schoeb T; Siegal GP; Alexander CB; Pardo A; Selman M
Am J Pathol; 2005 Aug; 167(2):365-79. PubMed ID: 16049324
[TBL] [Abstract][Full Text] [Related]
5. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
Mizuno S; Matsumoto K; Li MY; Nakamura T
FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
[TBL] [Abstract][Full Text] [Related]
6. Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury.
Bulvik R; Biton M; Berkman N; Breuer R; Wallach-Dayan SB
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210149
[TBL] [Abstract][Full Text] [Related]
7. 5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo.
Löfdahl A; Rydell-Törmänen K; Müller C; Martina Holst C; Thiman L; Ekström G; Wenglén C; Larsson-Callerfelt AK; Westergren-Thorsson G
Physiol Rep; 2016 Aug; 4(15):. PubMed ID: 27482070
[TBL] [Abstract][Full Text] [Related]
8. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.
Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH
J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178
[TBL] [Abstract][Full Text] [Related]
9. Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution.
Liu X; Wong SS; Taype CA; Kim J; Shentu TP; Espinoza CR; Finley JC; Bradley JE; Head BP; Patel HH; Mah EJ; Hagood JS
Lab Invest; 2017 Mar; 97(3):256-267. PubMed ID: 28165468
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis.
Chen L; Yang Y; Peng X; Yan H; Zhang X; Yin L; Yu H
Aging (Albany NY); 2020 May; 12(9):8339-8351. PubMed ID: 32396525
[TBL] [Abstract][Full Text] [Related]
11. Thy1 up-regulates FasL expression in lung myofibroblasts via Src family kinases.
Cohen PY; Breuer R; Wallach-Dayan SB
Am J Respir Cell Mol Biol; 2009 Feb; 40(2):231-8. PubMed ID: 18676775
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
[TBL] [Abstract][Full Text] [Related]
13. Single-nucleus chromatin accessibility identifies a critical role for TWIST1 in idiopathic pulmonary fibrosis myofibroblast activity.
Valenzi E; Bahudhanapati H; Tan J; Tabib T; Sullivan DI; Nouraie M; Sembrat J; Fan L; Chen K; Liu S; Rojas M; Lafargue A; Felsher DW; Tran PT; Kass DJ; Lafyatis R
Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37142338
[TBL] [Abstract][Full Text] [Related]
14. Methionine aminopeptidase-2 as a selective target of myofibroblasts in pulmonary fibrosis.
Kass D; Bridges RS; Borczuk A; Greenberg S
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):193-201. PubMed ID: 17446530
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
16. Thy1 (+) and (-) lung fibrosis subpopulations in LEW and F344 rats.
McIntosh JC; Hagood JS; Richardson TL; Simecka JW
Eur Respir J; 1994 Dec; 7(12):2131-8. PubMed ID: 7536165
[TBL] [Abstract][Full Text] [Related]
17. Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts.
Dias HB; de Oliveira JR; Donadio MVF; Kimura S
PLoS One; 2019; 14(9):e0222202. PubMed ID: 31509566
[TBL] [Abstract][Full Text] [Related]
18. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
[TBL] [Abstract][Full Text] [Related]
19. Amine oxidase activity regulates the development of pulmonary fibrosis.
Marttila-Ichihara F; Elima K; Auvinen K; Veres TZ; Rantakari P; Weston C; Miyasaka M; Adams D; Jalkanen S; Salmi M
FASEB J; 2017 Jun; 31(6):2477-2491. PubMed ID: 28251930
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]